Howard Zhang
  1. Partner

Mr. Zhang is a partner in Davis Polk’s Corporate Department, resident in Beijing. He focuses on mergers and acquisitions, including private equity portfolio investments, buyouts, joint ventures and strategic investment transactions. He also advises clients on cross-border securities and general corporate matters.

Work Highlights

M&A Representations
  • iKang Healthcare on its acquisition by Yunfeng Capital and Alibaba
  • Tongcheng Network Technology on its combination with E-dragon Holdings
  • Tencent and Tencent Music Entertainment ("TME") with respect a share swap transaction between TME and Spotify and the purchase of minority stake by Tencent in Spotify
  • China Biologic Products on its approximately $513 million acquisition of 80% equity interest in Tianxinfu
  • China Lodging Group on its approximately $531 million acquisition of Crystal Orange Hotel Holdings
  • iQiyi on its $1.53 billion convertible notes financing
  • The buyer group on its going private transaction of KongZhong Corporation
  • The buyer group on its going private transaction of Synutra International
  • Special committee of Origin Agritech on its sale of commercial seed production and distribution business
  • IDG Capital on its acquisition of International Data Group
  • Fujian Thai Hot Investment:
    • on its $1.4 billion acquisition of the insurance operations of Dah Sing
    • on its acquisition of a majority interest in Alliance HealthCare Services
  • Freeport-McMoRan on the sale of its interest in TF Holdings
  • Huatai Securities on its $780 million acquisition of AssetMark
  • Ingram Micro on its $6 billion acquisition by Tianjin Tianhai to become part of HNA Group
  • Postal and Savings Bank of China on its $7 billion sale of shares to strategic investors
  • Special committee of Jiayuan.com on its acquisition by Baihe
  • IDG Capital on its investment in DMALL and SouFun
  • Universal and Comcast on a proposed joint venture with Beijing Shouhuan for the development and operation of a theme park and resort in China
  • Representative management on its going private transaction of iSoftStone
  • Baidu:
    • on its investment in Cheetah Mobile
    • on its $1.9 billion acquisition of 91 Wireless Websoft
    • on its $370 million acquisition of the online video business of PPS
    • on its acquisition of Providence Equity Partners’ stake in iQiyi
    • on the Series B financing of Qiyi.com
    • on its $306 million investment in Qunar
  • CNOOC on its $17.9 billion acquisition of Nexen
  • Synutra in a partnership agreement with Sodiaal
  • Dalian Wanda on its $2.6 billion acquisition of AMC Entertainment
  • Unitas Capital on its acquisition of a majority stake in ZTE NetView
  • Warburg Pincus:
    • on purchase of equity interest in China Biological Products
    • on its acquisition of a majority stake in Beijing Fanhua Datong Investment Management
  • IDG Ventures on its going private transaction of Soko Fitness & Spa Group
  • Charles River Laboratory International on its approximately $1.6 billion acquisition of  Wuxi PharmaTech
  • A consortium led by the management team of Amdocs China and IDG Capital in its agreement to acquire the China operations from Amdocs
  • Stable Investment Corporation on its investment in China Lumena New Materials
  • COFCO on its investment in Smithfield Foods
  • Baring Private Equity Asia in financing a management buyout of Asian American Gas
  • CCMP Asia on its acquisition of the flue gas desulphurization business from a publicly listed company in China
  • Yahoo on its acquisition of a Chinese search engine
  • Focus Media on its acquisition of Framedia and Allyes Information Technology
  • Shanda on its acquisition of a significant stake in Sina
Capital Markets
  • The underwriters on:
    • AAG Energy on its $294 million Hong Kong IPO and global offering
    • China Xueda on its $146.7 million US IPO
    • ChinaCache on its $96 million US IPO
    • Zhaopin on its $75.7 million US IPO
    • 21Vianet Group on its $224.3 million US IPO
    • CSUN on its $93.5 million US IPO
  • iKang Healthcare Group on its $152.7 million IPO and $40 million concurrent private placement
  • Nexteer Automotive Group on its $260 million Hong Kong IPO and global offering
  • iKang Healthcare Group on its issuance and sale of $100 million of preferred stock
  • PICC on its $3.6 billion Hong Kong IPO and global offering – the largest Hong Kong IPO for 2011 and 2012
  • China Nonferrous Mining Corporation on its $252 million Hong Kong IPO and global offering
  • New China Life Insurance Company on its $1.9 billion global offering and dual listing in Hong Kong and Shanghai
  • Agricultural Bank of China on its $22.1 billion global offering and dual listing in Hong Kong and Shanghai
  • China Lodging on its $126.8 million US IPO
  • Shanda Interactive Entertainment on its US IPO
  • ATA on its US IPO
  • Acorn International’s on its US IPO
  • China Finance Online on its US IPO
  • China Unicom on its convertible bonds offering
  • Mengniu on its $500 million bond offering

Recognition

Mr. Zhang is recognized as a leading lawyer in various industry publications:

  • Asian Legal Business – China Top 10 M&A Lawyer: International Law Firm, 2017 
  • Chambers Global
  • Chambers Asia-Pacific
  • IFLR1000  Private equity, M&A, Capital markets: Equity  Highly Regarded
  • Expert Guide to the World’s Leading Private Equity Lawyers

Of Note

  • Member, Dean’s Advisory Board, Boston University Law School

Professional History

  • Davis Polk since 2008

Bar Admissions

  • Commonwealth of Massachusetts
  • Beijing Ministry of Justice - Registered

Education

  • B.A., Shanghai International Studies University, 1981
  • J.D., Boston University School of Law, 1993
    • American Jurisprudence Award
    • Topics Editor, International Law Journal

Languages

  • Mandarin
  • English